Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Blood pressure trial aims to stop dementia before it starts

NCT ID NCT05106036

First seen Jan 04, 2026 · Last updated Jun 19, 2026 · Updated 26 times

Summary

This study tests whether helping doctors manage high blood pressure more aggressively can prevent cognitive decline and dementia in adults aged 70 and older. 4,000 participants will be randomly assigned to either a special decision-support tool for their doctors or usual care. The goal is to see if better blood pressure control can keep minds sharp longer.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • UT Southwestern Medical Center

    RECRUITING

    Dallas, Texas, 75390, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Clinical decision support tool and team-based care for blood pressure management

What this could lead to

If successful, this could show that lowering blood pressure in older adults helps prevent memory loss and dementia.

What could go wrong

This is a pragmatic trial testing a care approach, not a new drug. Results may be modest, and cognitive benefits are not guaranteed.

Conditions

The condition(s) this trial relates to.

Cognitive Dysfunction hypertensive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.